Guizhou Kekai Medicine Co., Ltd. announced that it will receive CNY 461,450,506.01 in an equity round of funding on November 6, 2021. The transaction will include participation from returning investor Guizhou Xinbang Pharmaceutical Co., Ltd. Pursuant to the transaction the registered capital of the company will be CNY 2,200,000,000. The transaction has been approved by investors 5th session of it's 8th directorate.